NOV | Nephroblastoma overexpressed | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CAMK2N2 | Calcium/calmodulin-dependent protein kinase II inhibitor 2 | Predicted intracellular proteins
| | | | | Group enriched |
CHGB | Chromogranin B (secretogranin 1) | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
NPY | Neuropeptide Y | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
FDX1 | Ferredoxin 1 | Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enriched |
INA | Internexin neuronal intermediate filament protein, alpha | Predicted intracellular proteins
| | | | | Group enriched |
MGARP | Mitochondria-localized glutamic acid-rich protein | Predicted membrane proteins
| | | | | Tissue enriched |
RTL1 | Retrotransposon-like 1 | Predicted membrane proteins
| | | | | Group enriched |
AKR1B1 | Aldo-keto reductase family 1, member B1 (aldose reductase) | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
KCNK9 | Potassium channel, subfamily K, member 9 | Disease related genes FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Group enriched |
SYT4 | Synaptotagmin IV | Predicted intracellular proteins
| | | | | Group enriched |
NR0B1 | Nuclear receptor subfamily 0, group B, member 1 | Cancer-related genes Disease related genes Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
RET | Ret proto-oncogene | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
SOAT1 | Sterol O-acyltransferase 1 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
ATP2B3 | ATPase, Ca++ transporting, plasma membrane 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
FAM135B | Family with sequence similarity 135, member B | Predicted intracellular proteins
| | | | | Group enriched |
MYT1 | Myelin transcription factor 1 | Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
RGN | Regucalcin | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
SCARB1 | Scavenger receptor class B, member 1 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
MLXIPL | MLX interacting protein-like | Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins Transcription factors
| | | | | Group enriched |
PEG10 | Paternally expressed 10 | Predicted intracellular proteins
| | | | | Group enriched |
SORBS2 | Sorbin and SH3 domain containing 2 | Predicted intracellular proteins
| | | | | Group enriched |
AOX1 | Aldehyde oxidase 1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CDH2 | Cadherin 2, type 1, N-cadherin (neuronal) | CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
COL22A1 | Collagen, type XXII, alpha 1 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FIBCD1 | Fibrinogen C domain containing 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
GSTT2B | Glutathione S-transferase theta 2B (gene/pseudogene) | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
L1CAM | L1 cell adhesion molecule | CD markers Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LONRF2 | LON peptidase N-terminal domain and ring finger 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
MYO7A | Myosin VIIA | Cytoskeleton related proteins Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
NR4A2 | Nuclear receptor subfamily 4, group A, member 2 | Cancer-related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
PPM1E | Protein phosphatase, Mg2+/Mn2+ dependent, 1E | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
RTBDN | Retbindin | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SEPT4 | Septin 4 | Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
SSTR5 | Somatostatin receptor 5 | FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
SULT2A1 | Sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
SV2C | Synaptic vesicle glycoprotein 2C | Predicted membrane proteins
| | | | | Tissue enhanced |
SYT2 | Synaptotagmin II | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
TBX3 | T-box 3 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |